Harmony Biosciences Holdings's market cap is currently ―. The company's EPS TTM is $2.132; its P/E ratio is 13.99; Harmony Biosciences Holdings is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $0.62. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 168.41M	$ 160.27M	$ 134.22M	$ 119.13M	-
Gross Profit	$ 125.26M	$ 127.97M	$ 109.21M	$ 98.35M	-
EBIT	-	$ 63.63M	$ 56.11M	$ 40.42M	-
EBITDA	-	$ 70.27M	$ 61.92M	$ 46.27M	-
Net Income Common Stockholders	$ 26.61M	$ 38.46M	$ 34.30M	$ 29.48M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 353.46M	$ 370.67M	$ 370.98M	$ 343.88M	$ 323.12M
Total Assets	$ 811.45M	$ 777.77M	$ 760.18M	$ 715.09M	$ 673.87M
Total Debt	$ 193.57M	$ 197.13M	$ 191.49M	$ 191.56M	$ 191.65M
Net Debt	$ -159.89M	$ -173.54M	$ -179.50M	$ -152.31M	$ -131.47M
Total Liabilities	$ 344.46M	$ 296.43M	$ 275.01M	$ 272.05M	$ 673.87M
Stockholders Equity	$ 466.99M	$ 481.33M	$ 485.17M	$ 443.04M	$ 402.84M
Cash Flow	-
Free Cash Flow	-	$ 63.10M	$ 36.86M	$ 42.56M	$ 26.68M
Operating Cash Flow	$ 76.67M	$ 63.10M	$ 37.06M	$ 42.56M	-
Investing Cash Flow	$ -36.06M	$ -813.00K	$ -7.77M	$ -1.79M	-
Financing Cash Flow	$ -53.52M	$ -55.10M	$ -339.00K	$ 3.41M	-

Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

Income Statement >

Harmony Biosciences Holdings Debt to Assets

Balance Sheet >

Harmony Biosciences Holdings Cash Flow

Cash Flow >

Harmony Biosciences Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing